The role of AIRE in human autoimmune disease

Nature Reviews Endocrinology

Volumn 7, Issue 1, 2011, Pages 25-33

  Akirav, Eitan M ^a   Ruddle, Nancy H ^a   Herold, Kevan C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; GENE MUTATION; GENOTYPE; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; THYMUS;

AUTOIMMUNE DISEASES; HUMANS; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 78650309706     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2010.200     Document Type: Review

References (88)

1. Bubanovic, I. V. Crossroads of extrathymic lymphocytes maturation pathways. Med. Hypotheses 61, 235-239 (2003).
2. Pantelouris, E. M. Absence of thymus in a mouse mutant. Nature 217, 370-371 (1968).
3. Cunliffe, V. T., Furley, A. J. & Keenan, D. Complete rescue of the nude mutant phenotype by a wild-type Foxn1 transgene. Mamm. Genome 13, 245-252 (2002).
4. Lind, E. F, Prockop, S. E., Porritt, H. E. & Petrie, H. T. Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. J. Exp. Med. 194, 127-134 (2001).
5. Pearse, M. et al. A murine early thymocyte developmental sequence is marked by transient expression of the interleukin 2 receptor. Proc Natl Acad. Sci. USA 86, 1614-1618 (1989).
6. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate v(D)J rearrangement. Cell 68, 855-867 (1992).
7. Jameson, S. C, Hogquist, K. A. & Bevan, M. J. Positive selection of thymocytes. Annu. Rev. Immunol. 13, 93-126 (1995).
8. Kisielow, P, Teh, H. S., Blüthmann, H. & von Boehmer, H. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335, 730-733 (1988).
9. Scollay, R. G., Butcher, E. C & Weissman, I. L. Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur. J. Immunol. 10, 210-218 (1980).
10. Klein, L, Hinterberger, M., Wirnsberger, G. & Kyewski, B. Antigen presentation in the thymus for positive selection and central tolerance nduction. Nat Rev. Immunol. 9, 833-844 (2009).
11. Silva-Santos, B., Pennington, D. J. & Hayday, A. C Lymphotoxin-mediated regulation of gammadelta cell differentiation by alphabeta T cell progenitors. Science 307, 925-928 (2005).
12. Chin, R. K. et al. Lymphotoxin pathway directs thymic Aire expression. Nat Immunol. 4, 1121-1127 (2003)
13. Martins, V. C, Boehm, T. & Bleul, C C Ltßr signaling does not regulate Aire-dependent transcripts in medullary thymic epithelial cells. J. Immunol. 181, 400-407 (2008).
14. Venanzi, E. S., Melamed, R., Mathis, D. & Benoist, C The variable immunological self: genetic variation and nongenetic noise in Aire-regulated transcription. Proc. Natl Acad. Sci. USA 105, 15860-15865 (2008).
15. Derbinski, J. et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202, 33-45 (2005).
16. Anderson, M. S. et al. Projection of an mmunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002).
17. Abramson, J., Giraud, M., Benoist, C & Mathis, D. Aire's partners in the molecular control of immunological tolerance. Cell 140, 123-135 (2010).
18. Guerau-de-Arellano, M., Mathis, D. & Benoist, C Transcriptional impact of Aire varies with cell type. Proc Natl Acad. Sci. USA 105, 14011-14016 (2008).
19. Ferguson, B. J. et al. AIRE's CARD revealed, a new structure for central tolerance provokes transcriptional plasticity. J. Biol. Chem. 283, 1723-1731 (2008).
20. Mathis, D. & Benoist, C A decade of AIRE. Nat Rev. Immunol. 7, 645-650 (2007).
21. Jordan, M. S. et al. Thymic selection of CD4+ CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2, 301-306 (2001).
22. Heino, M. et al. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur. J. Immunol. 30, 1884-1893 (2000).
23. Kogawa, K. et al. Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol. Lett 80, 195-198 (2002).
24. Su, M. A. et al. Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire. J. Clin. Invest 118, 1712-1726 (2008).
25. Lee, J. W. et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to ntestinal self. Nat Immunol. 8, 181-190 (2007).
26. Gardner, J. M. et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321, 843-7 (2008).
27. Poliani, P L. et al. Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. Am. J. Pathol. 176, 1104-1112 (2010).
28. Ikegami, H. Animal models of autoimmune polyglandular syndrome. Endocrinol. Metab. Clin. North Am. 31, 431-439 (2002).
29. Ramsey, C et al. Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator. Eur. J. Immunol. 36, 305-317 (2006).
30. Gotter, J. & Kyewski, B. Regulating self-tolerance by deregulating gene expression. Curr. Opin. Immunol. 16, 741-745 (2004).
31. Johnnidis, J. B. et al. Chromosomal clustering of genes controlled by the aire transcription factor Proc. Natl Acad. Sci. USA 102, 7233-7238 (2005)
32. Jiang, W., Anderson, M. S., Bronson, R., Mathis, D. & Benoist, C Modifier loci condition autoimmunity provoked by Aire deficiency. J. Exp. Med. 202, 805-815 (2005).
33. Fan, Y. et al. Thymus-specific deletion of insulin nduces autoimmune diabetes. EMBO J. 28, 2812-2824 (2009).
34. Babaya, N. et al. A new model of insulin-deficient diabetes: male NOD mice with a single copy of Ins1 and no Ins2. Diabetologia 49, 1222-1228 (2006).
35. Jaeckel, E., Lipes, M. A. & von Boehmer, H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol. 5, 1028-1035 (2004).
36. Kuroda, N. et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J. Immunol. 174, 1862-1870 (2005).
37. Niki, S. et al. Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice. J. Clin. Invest 116, 1292-1301 (2006).
38. Björses, P et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet 66, 378-392 (2000)
39. Wolff, A. S. et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J. Clin. Endocrinol. Metab. 92, 595-603 (2007).
40. Piirilä, H., väliaho, J. & vihinen, M. mmunodeficiency mutation databases (IDbases). Hum. Mutat 27, 1200-1208 (2006), http://bioinf.uta.fi/baseroot/[online] (2010).
41. Ahonen, P Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin. Genet 27; 535-542 (1985).
42. Zlotogora, J. & Shapiro, M. S. Polyglandular autoimmune syndrome type I among Iranian Jews. J. Med. Genet 29, 824-826 (1992).
43. Aaltonen, J., Björses, P, Sandkuijl, L, Perheentupa, J. & Peltonen, L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type assigned to chromosome 21. Nat Genet 8, 83-87 (1994).
44. Björses, P et al. Genetic homogeneity of autoimmune polyglandular disease type I. Am. J. Hum. Genet 59, 879-886 (1996).
45. Aaltonen, J. et al. High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res. 7, 820-829 (1997).
46. Kudoh, J. et al. Localization of 16 exons to a 450-kb region involved in the autoimmune polyglandular disease type I (APECED) on human chromosome 21q22.3. DNA Res. 4, 45-52 (1997).
47. Nagamine, K. et al. Positional cloning of the APECED gene. Nat Genet 17, 393-398 (1997).
48. Vogel, A. et al. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology 33, 1047-1052 (2001).
49. Peterson, P, Pitkänen, J., Sillanpää, N. & Krohn, K. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin. Exp. Immunol. 135, 348-357 (2004).
50. Pearce, S. H. et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am. J. Hum. Genet 63, 1675-1684 (1998).
51. Heino, M. et al. Mutation analyses of North American APS-1 patients. Hum. Mutat 13, 69-74 (1999).
52. [No authors listed] An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17, 399-403 (1997).
53. Cervato, S. et al. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy- candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin. Endocrinol. (Oxf.) 70, 421-428 (2009).
54. Cihakova, D. et al. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum. Mutat 18, 225-232 (2001).
55. Heino, M. et al. APECED mutations in the autoimmune regulator (AIRE) gene. Hum. Mutat 18, 205-211 (2001).
56. Husebye, E. S., Perheentupa, J., Rautemaa, R. & Kämpe, O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med. 265, 514-529 (2009).
57. Podkrajsek, K. T. et al. Detection of a complete autoimmune regulator gene deletion and two additional novel mutations in a cohort of patients with atypical phenotypic variants of autoimmune polyglandular syndrome type 1. Eur. J. Endocrinol. 159, 633-639 (2008).
58. Buzi, F. et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria? J. Clin. Endocrinol. Metab. 88, 3146-3148 (2003).
59. Blizzard, R. M. & Kyle, M. Studies of the adrenal antigens and antibodies in Addison's disease. J. Clin. Invest 42, 1653-1660 (1963).
60. Hung, W., Migeon, C J. & Parrott, R. H. A possible autoimmune basis for Addison's disease in three siblings, one with idiopathic hypoparathyroidism, pernicious anemia and superficial moniliasis. N. Engl. J. Med. 269, 658-663 (1963).
61. Kogut, M. D. & Brinegar, C H. Jr. Addison's disease and diabetes mellitus. J. Pediatr. 81, 307-311 (1972).
62. Alimohammadi, M. et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N. Engl. J. Med. 358, 1018-1028 (2008).
63. Meager, A. et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 3, e289 (2006).
64. Kisand, K. et al. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood 112, 2657-2666 (2008).
65. Puel, A. et al. Autoantibodies against IL-17A, L-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207, 291-297 (2010).
66. Kisand, K. et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207, 299-308 (2010).
67. Littman, D. R. & Rudensky, A. Y. Th17 and regulatory T cells in mediating and restraining nflammation. Cell 140, 845-858 (2010).
68. Rautemaa, R., Hietanen, J., Niissalo, S., Pirinen, S. & Perheentupa, J. Oral and oesophageal squamous cell carcinoma\a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol. 43, 607-613 (2007).
69. Ward, L. et al. Severe autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J. Clin. Endocrinol. Metab. 84, 844-852 (1999).
70. Padeh, S., Theodor, R., Jonas, A. & Passwell, J. H. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch. Dis. Child. 76, 532-534 (1997).
71. Dhodapkar, M. v., Lust, J. A. & Phyliky, R. L. T-cel large granular lymphocytic leukemia and pure red cell aplasia in a patient with type autoimmune polyendocrinopathy: response to mmunosuppressive therapy. Mayo Clin. Proc 69, 1085-1088 (1994).
72. Ulinski, T. et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant mmunosuppression on disease activity. J. Clin. Endocrinol. Metab. 91, 192-195 (2006).
73. Ströbel, P et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J. Pathol. 211, 563-571 (2007).
74. Evoli, A. et al. Thymoma in patients with MG: characteristics and long-term outcome. Neurology 59, 1844-1850 (2002).
75. Cetani, F et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 86, 4747-4752 (2001).
76. Björses, P, Aaltonen, J., Horelli-Kuitunen, N., Yaspo, M. L. & Peltonen, L. Gene defect behind APECED: a new clue to autoimmunity. Hum. Mol. Genet 7, 1547-1553 (1998).
77. Thornton, A. M. et al. Expression of Helios, an karos transcription factor family member, differentiates thymic-derived from peripherally nduced Foxp3+ T regulatory cells. J. Immunol. 184, 3433-3441 (2010).
78. Ryan, K. R. et al. CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J. Allergy Clin. Immunol. 116, 1158-1159 (2005).
79. Kekäläinen, E. et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Immunol. 178, 1208-1215 (2007).
80. Liston, A., Lesage, S., Wilson, J., Peltonen, L. & Goodnow, C C Aire regulates negative selection of organ-specific T cells. Nat Immunol. 4, 350-354 (2003).
81. Liston, A. et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad. Sci. USA 105, 11903-11908 (2008).
82. Aschenbrenner, K. et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol. 8, 351-358 (2007).
83. Gebre-Medhin, G. et al. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett 412, 439-445 (1997). (Pubitemid 27337086)
84. Tuomi, T. et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 81, 1488-1494 (1996). (Pubitemid 26118581)
85. Söderbergh, A. et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 89, 557-562 (2004).
86. Ekwall, O. et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352, 279-283 (1998).
87. Krohn, K., Uibo, R., Aavik, E., Peterson, P & Savilahti, K. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet 339, 770-773 (1992).
88. Hubert, F. X. et al. Aire-deficient C57BL/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype. J. Immunol. 182, 3902-3918 (2009).